Teladoc Health Makes A1C Testing Easier for Members with Diabetes
August 10 2022 - 9:00AM
Teladoc Health (NYSE: TDOC), the global leader in whole-person
care, announced today the addition of a home A1C testing program to
its Livongo by Teladoc Health chronic care solution, making it
easier for members to manage and control their diabetes. Livongo by
Teladoc Health members will have the option to receive at-home A1C
tests provided by LetsGetChecked, a leading healthcare solutions
company that enables providers to administer diagnostics and care
directly into the homes of patients. The announcement comes as new
company data shows that 58% of members opt for the at-home service
when given the chance, with a three to four times greater consumer
test return rate than other options on the market.
Coupled with the highly successful Livongo by Teladoc Health
diabetes management program and whole-person integrated programs to
address hypertension, weight, mental health and other frequent
comorbidities, 87% of members using the in-home test reported a
controlled A1C of 8% or less. For context, the commercial health
plan average was 54%[1] of members having a controlled A1C of 8% or
less, reinforcing the positive impact of the Teladoc Health
program.
The results of the new at-home testing program are good news for
individuals living with diabetes as well as those providing and
purchasing their care. At-home testing closes gaps in care and
outcomes reporting, improving clinical quality and streamlining the
sharing of more complete data with HEDIS and other measures
critical to both quality improvement and reimbursement.
“Meeting people where they are is paramount for enabling better
clinical outcomes,” said Vidya Raman-Tangella, chief medical
officer at Teladoc Health. “Social and environmental factors
account for 50-60% of health, and we are addressing persistent
challenges by offering in-home testing. The data gathered by giving
more people necessary tools will help us to create actionable
insights that fuel a more individualized approach to health
care.”
Livongo by Teladoc Health members receive the at-home A1C tests
– also known as the hemoglobin A1C or HbA1c test – with one-click
on their blood glucose meters. A1C is one of the commonly used
tests to diagnose pre-diabetes and diabetes, and the main test to
help members and their care teams manage diabetes. Individuals
self-administer the sample blood collection via finger prick, and
based on their results, are offered personalized next steps aimed
to help members lower their A1C.
“At-home testing will not only help members better understand
their risk, but better manage their conditions and live their
healthiest lives on their own terms,” said Kelly Bliss, U.S. Group
Health President at Teladoc Health. “For the more than 37 million
people in the United States living with diabetes, this is a quick
and effortless way for us to engage with members, at the moment
they are managing their diabetes.”
The diagnostic testing, provided by LetsGetChecked, is key to
ensuring equitable access to care as many populations may not have
easy access to a physician or specialist who can perform a check-up
or administer these tests. These at-home tests are also often used
as a supplement to routine Livongo by Teladoc Health remote
diabetes monitoring, which was recently proven to improve health
and blood glucose measures regardless of a member’s socioeconomic
status.
“The vertically integrated and modular LetsGetChecked platform
plays an essential role in reaching underserved or
geographically-isolated individuals who often face significant
barriers to routine and recommended testing,” said Peter Foley,
Founder & CEO of LetsGetChecked. “Through our collaboration
with Teladoc Health, we will increase access to care and provide
data enabled insights on population-based health initiatives, a
particularly critical tool to address the prevalence of chronic
health issues.”
About Teladoc Health Teladoc Health empowers
all people everywhere to live their healthiest lives by
transforming the healthcare experience. As the world leader in
whole-person virtual care, Teladoc Health uses proprietary health
signals and personalized interactions to drive better health
outcomes across the full continuum of care, at every stage in a
person’s health journey. Ranked #1 among direct-to-consumer
telehealth providers in the J.D. Power 2021 U.S. Telehealth
Satisfaction Study, Teladoc Health leverages more than a decade of
expertise and data-driven insights to meet the growing virtual care
needs of consumers and healthcare professionals. For more
information, please visit www.teladochealth.com or
follow @TeladocHealth on Twitter.
About LetsGetChecked LetsGetChecked is a global
healthcare solutions company that provides the tools to manage
health from home through direct access to diagnostic testing,
virtual care, and medication delivery for a wide range of health
and wellness conditions. LetsGetChecked’s end-to-end model includes
manufacturing, logistics, lab analysis, clinician support, and
prescription fulfillment. Founded in 2015, the company empowers
people with accessible health information and care to live longer,
happier lives. LetsGetChecked is available nationwide
in the United States, the United Kingdom, and most EU countries. It
is co-headquartered in Dublin and New York. For more information,
please visit www.letsgetchecked.com or follow @LetsGetChecked
onTwitter.
ContactCarolyn W.
Edwardscarolyn.edwards@teladochealth.com+1 321-795-1952
Source: Teladoc Health, Inc. – General
Teladoc Health (NYSE:TDOC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Teladoc Health (NYSE:TDOC)
Historical Stock Chart
From Sep 2023 to Sep 2024